Prognosis
Another Challenge for Vaccine Makers: Keeping It at Minus-112 Degrees
- Translate Bio’s experimental Covid-19 shot is in animal tests
- Vaccine must be ‘best-suited for everyone,’ CEO Renaud says
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
A little-known biotech is working to surmount a hurdle that may hinder global access to a coronavirus vaccine.